SEC Form 4 · accession 0001127602-16-060377
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Bartlett Foote
Director
Period of report
Aug 5, 2016
Accepted (ET)
Aug 16, 2016 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 5, 2016 | S | 300 | $35.355 | D | 16,311 | D | |
| Common Stock | Aug 5, 2016 | S | 8,280 | $35.35 | D | 16,611 | D | |
| Common Stock | Aug 5, 2016 | M | 8,580 | $27.24 | A | 24,891 | D | |
| Common Stock | Aug 5, 2016 | S | 5,305 | $35.35 | D | 16,311 | D | |
| Common Stock | Aug 5, 2016 | S | 200 | $35.346 | D | 21,616 | D | |
| Common Stock | Aug 5, 2016 | S | 300 | $35.34 | D | 21,816 | D | |
| Common Stock | Aug 5, 2016 | S | 200 | $35.33 | D | 22,116 | D | |
| Common Stock | Aug 5, 2016 | S | 100 | $35.32 | D | 22,316 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F1 | $27.24 | Aug 5, 2016 | M | 8,580 | D | Jul 29, 2011 | Jul 29, 2017 | Common Stock | 8,580 | 0 | D |
Explanation of responses
- F1Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.